Call Us @ 0172 - 4680800 | info@indswift.com | NETWORKS | NSE - BSE

Investors

Unaudited Financial Results for the Quarter ended on 31st December, 2004
PARTICULARS
For the Quarter ended
31.12.2004
(Unaudited)
For the Quarter ended
31.12.2003
(Unaudited)
For Nine Months
ended 31.12.2004 (Unaudited)
For the Nine Months
Ended 31.12.2003 (Unaudited)
Year Ended
31.03.2004 (Audited)
INCOME FROM OPERATIONS          
SALES 6400.12 5334.33 18169.41 15208.77 21183.70
CONTRACT RESEARCH 0.00 0.00 65.00 0.00 64.95
TOTAL (A) 6400.12 5334.33 18234.41 15208.77 21248.65
OTHER INCOME          
PROFIT ON SALEOF SHARES 1050.68 32.18 1063.68 37.24 53.50
OTHER INCOME 13.71 10.49 37.40 24.98 125.38
TOTAL (B) 1064.39 42.67 1101.08 62.22 178.88
           
GRAND TOTAL(A+B) 7464.51 5377.00 19335.49 15270.99 21427.53
           
TOTAL EXPENDITURE 5677.43 4802.67 16157.40 13663.42 19916.54
           
DECREASE IN STOCK IN TRADE 1830.34 -327.82 1668.13 -602.14 -1884.50
CONSUMPTION OF RAW MATERIAL 2996.41 4403.19 12004.28 12165.56 18108.87
COST OF SALES 4826.75 4075.37 13672.41 11563.42 16224.37
STAFF COST 190.48 178.28 552.50 481.97 696.55
OTHER EXPENSES 660.20 549.02 1932.49 1618.03 2341.92
INTEREST 155.51 139.72 457.32 451.43 558.71
DEPRECIATION 26.20 25.95 89.15 71.96 94.99
PROFIT BEFORE TAX 1605.37 408.66 2631.62 1084.18 1510.99
PROVISION FOR TAX 41.60 30.65 118.57 81.31 124.07
PROVISION FOR DEFFERRED TAX 111.25 60.99 170.64 76.73 100.91
NET PROFIT 1452.52 317.02 2342.41 926.14 1286.01
PAID UP SHARE CAPITAL 611.57 439.50 611.57 439.50 571.57
RESERVES (EXCLUDING REVALUATION RESERVES) ---- ---- ---- ---- 6574.23
E.P.S.(Rs.)BASIC 23.75 7.21 38.30 21.07 23.44
NOTES:
1. During the quarter under review, the net profit of the Company jumped by 358% as compared to the corresponding quarter of the previous year.

2. During the quarter, the Board of Directors of the Company, have allotted 15,00,000 Zero Coupon Optionally Convertible Warrants on preferential basis to promoters/directors of the Company and outside bodies corporate, in accordance with Section 81(1A) of the Companies Act, 1956 read with SEBI (Disclosure and Investor Protection) Guidelines on Preferential Issues.

3. The Company is exclusively in the Pharmaceutical business segment.

4. The Company has received 9 complaints during the quarter under review which were duly redressed to the satisfaction of the shareholders during the same quarter and as such, there were no pending complains as on 31st December, 2004.

5. The above financial results were taken on record by the Board at its meeting held on 22nd January, 2005.
 
By Order of the Board
 
Dated: 22.01.2005
(Gopal Munjal)
Place: Chandigarh
Chairman